Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-14

Clinical Trial Update: Safety Study of the Aethlon Hemopurifier [NA]

View source ↗

Summary

Safety study of the Aethlon Hemopurifier has been terminated. It targeted patients with End-stage renal disease and Hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aethlon Hemopurifier

Snippet

Sponsor: Aethlon Medical Inc. | Conditions: End Stage Renal Disease, Hepatitis C Infection | NA | Status: TERMINATED